MetaCap

Prothena Insider Trades

NASDAQ: PRTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.84+0.23 (+2.67%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $1.82M
Sales
0 · $0
Shares bought / sold
215.00K / 0
Net activity
Net buying $1.8 million

Prothena insider activity

Over the last 12 months, Prothena insiders reported 2 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $1.8 million and sold $0 worth of stock, for net insider buying of $1.8 million. The most recent filing shows SCULLY WILLIAM P (10% Owner) buying 90,000 shares at $8.57 on Oct 8, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PRTA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PRTA insider transactions

Prothena insider transactions
DateInsiderTypeSharesValueFiling
Oct 8, 2026SCULLY WILLIAM P10% OwnerBuy90,000$770.90KForm 4
Oct 7, 2026SCULLY WILLIAM P10% OwnerBuy125,000$1.05MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related